Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Scholar Rock Holding Corporation (SRRK : NSDQ)

• Company Description    Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States. Number of Employees: 196

• Price / Volume Information    Yesterday's Closing Price: $44.05 Daily Weekly Monthly 20 Day Moving Average: 1,023,063 shares Shares Outstanding: 102.01 (millions) Market Capitalization: $4,493.43 (millions) Beta: 0.63 52 Week High: $48.28 52 Week Low: $22.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.54% -2.38% 12 Week 7.47% 5.73% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 BINNEY STREET 3RD FLOOR - CAMBRIDGE,MA 02142 USA ph: 857-259-3860 fax: 866-493-4935 ir@scholarrock.com http://www.scholarrock.com

• General Corporate Information    Officers Jay T. Backstrom - Chief Executive Officer and President David Hallal - Chairman of the Board of Directors Edward H. Myles - Chief Operating Officer & Chief Financial Officer Srinivas Akkaraju - Director Richard Brudnick - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 80706P103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 102.01 Most Recent Split Date: (:1) Beta: 0.63 Market Capitalization: $4,493.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.87 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.03 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 10.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 7.42% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 17.28 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -36.36% vs. Previous Quarter: 8.16% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - -121.95 06/30/25 - -127.11 ROA 12/31/25 - - 09/30/25 - -86.51 06/30/25 - -90.09 Current Ratio 12/31/25 - - 09/30/25 - 6.30 06/30/25 - 6.33 Quick Ratio 12/31/25 - - 09/30/25 - 6.30 06/30/25 - 6.33 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - 2.55 06/30/25 - 2.46 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.41 06/30/25 - 0.21 Debt-to-Capital 12/31/25 - - 09/30/25 - 28.91 06/30/25 - 17.58

Powered by Zacks Investment Research ©